Contemporary clinical management of monomorphic idiopathic premature ventricular contractions: results of the European Heart Rhythm Association survey
| Autor: | Antonio Sorgente, Michal M Farkowski, Konstantinos Iliodromitis, José M Guerra, Kristine Jubele, Julian K R Chun, Carlo de Asmundis, Serge Boveda |
|---|---|
| Přispěvatelé: | Heartrhythmmanagement, Clinical sciences |
| Rok vydání: | 2022 |
| Předmět: |
Premature ventricular contraction
Cardiomyopathy ventricular arrhythmias Idiopathic Ventricular Premature Complexes Antiarrhythmic drugs Treatment Outcome Ventricular arrhythmias Surveys and Questionnaires Physiology (medical) Catheter Ablation idiopathic Humans Catheter ablation EHRA survey Cardiology and Cardiovascular Medicine cardiomyopathy Anti-Arrhythmia Agents |
| Zdroj: | EUROPACE r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname |
| ISSN: | 1099-5129 |
| Popis: | On behalf of the European Heart Rhythm Association, we designed a survey, whose aim was to understand the trend(s) in the clinical management of idiopathic monomorphic premature ventricular contractions (PVCs) among European cardiologists and cardiac electrophysiologists. A total of 202 participants in the survey answered 27 multiple-choice questions on the clinical presentation, diagnosis and treatment of idiopathic monomorphic PVCs. The most common symptom in patients with idiopathic monomorphic PVCs is palpitations, according to the majority of responders (87%), followed by fatigue (29%) and dizziness (18%). Complete blood cell count, renal function with electrolytes levels, and thyroid function are the blood tests requested by the majority of respondents (65%, 92%, and 93%, respectively). Coronary artery disease and structural heart disease needs to be ruled out, according to the vast majority of participants (99%). A 24-h Holter ECG is the preferred ECG modality to assess the burden of PVCs (86% of respondents). Among the different option treatments, beta-blockers and class I antiarrhythmic drugs are by far (81% of respondents) the preferred pharmacological option in comparison with calcium antagonists and class III antiarrhythmic drugs. Catheter ablation has also a good reputation: 99% of responders are keen to use it, especially in patients with high burden of PVCs and when signs of cardiomyopathy occur. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|